Lyman, Meghan

Worsening Spread of Candida auris in the United States, 2019 to 2021

Lyman, M., Forsberg, K., Sexton, D. J., Chow, N. A., Lockhart, S. R., Jackson, B. R., & Chiller, T. (2023) · Annals of Internal Medicine

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 287

Candida auris Outbreak in a COVID-19 Specialty Care Unit — Florida, July–August 2020

Prestel, C., Anderson, E., Forsberg, K., Lyman, M., de Perio, M. A., Kuhar, D., Edwards, K., Rivera, M., Shugart, A., Walters, M., et al. (2021) · MMWR. Morbidity and Mortality Weekly Report

Antifungal resistance and susceptibilityInfection Control in Healthcare

Cited by 237

The Landscape of Candidemia During the Coronavirus Disease 2019 (COVID-19) Pandemic

Seagle, E. E., Jackson, B. R., Lockhart, S. R., Georgacopoulos, O., Nunnally, N. S., Roland, J., Barter, D. M., Johnston, H. L., Czaja, C. A., Kayalioglu, H., et al. (2022) · Clinical Infectious Diseases

Antifungal resistance and susceptibilityCOVID-19 Clinical Research Studies

Cited by 141

Epidemiology of Invasive Candidiasis

Bays, D., Jenkins, E., Lyman, M., Chiller, T., Strong, N., Ostrosky-Zeichner, L., Hoenigl, M., Pappas, P., & Thompson, G. (2024) · Clinical Epidemiology

Antifungal resistance and susceptibilityYeasts and Rust Fungi Studies

Cited by 109

Notes from the Field: Transmission of Pan-Resistant and Echinocandin-Resistant Candida auris in Health Care Facilities ― Texas and the District of Columbia, January–April 2021

Lyman, M., Forsberg, K., Reuben, J., Dang, T., Free, R., Seagle, E. E., Sexton, D. J., Soda, E., Jones, H., Hawkins, D., et al. (2021) · MMWR. Morbidity and Mortality Weekly Report

Antifungal resistance and susceptibilityInfection Control in Healthcare

Cited by 104

Candida auris‒Associated Hospitalizations, United States, 2017–2022

Benedict, K., Forsberg, K., Gold, J. A. W., Baggs, J., & Lyman, M. (2023) · Emerging Infectious Diseases

Antifungal resistance and susceptibilityYeasts and Rust Fungi Studies

Cited by 73

Population-Based Active Surveillance for Culture-Confirmed Candidemia — 10 Sites, United States, 2017–2021

Jenkins, E. N., Gold, J. A. W., Benedict, K., Lockhart, S. R., Berkow, E. L., Dixon, T., Shack, S. L., Witt, L. S., Harrison, L. H., Seopaul, S., et al. (2025) · MMWR. Surveillance Summaries

Antifungal resistance and susceptibilityYeasts and Rust Fungi Studies

Cited by 43

Progression from Candida auris Colonization Screening to Clinical Case Status, United States, 2016–2023

Baker, A. D., Gold, J. A. W., Forsberg, K., Jones, S., & Lyman, M. M. (2025) · Emerging Infectious Diseases

Antifungal resistance and susceptibilityInfection Control in Healthcare

Cited by 27

Persistent colonization of Candida auris among inpatients rescreened as part of a weekly surveillance program

Arenas, S. P., Persad, P. J., Patel, S., Parekh, D. J., Ferreira, T. B. D., Farinas, M., Sexton, D. J., Lyman, M., Gershengorn, H. B., & Shukla, B. S. (2024) · Infection Control & Hospital Epidemiology

Antifungal resistance and susceptibilityInfection Control in Healthcare

Cited by 21

Treatment practices for adults with candidemia at 9 active surveillance sites—United States, 2017–2018.

Gold, J. A. W., Seagle, E. E., Nadle, J., Barter, D. M., Czaja, C. A., Johnston, H., Farley, M. M., Thomas, S., Harrison, L. H., Fischer, J., et al. (2021) · Clinical Infectious Diseases

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 20